Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

David M Cognetti

Showing results (61-70 of 90) with videos related to

Pageof 9
Sort By:
Biomed Research International|January 19, 2016
Prognostic Indications of Elevated MCT4 and CD147 across Cancer Types: A Meta-AnalysisCory D Bovenzi, James Hamilton, Patrick Tassone, et al.
JAMA Otolaryngology-- Head & Neck Surgery|July 3, 2024
Obesity and Survival After Immune Checkpoint Inhibition for Head and Neck Squamous Cell CarcinomaEric V Mastrolonardo, Pablo Llerena, Joseph Lu, et al.
Cancer|October 3, 2023
Effect of preoperative programmed death-1 or programmed death ligand-1 immune check point inhibition on complications after surgery for primary head and neck cancerRamez Philips, Angela Alnemri, Dev Amin, et al.
JAMA Otolaryngology-- Head & Neck Surgery|July 9, 2023
Differences in Functional and Survival Outcomes Between Patients Receiving Primary Surgery vs Chemoradiation Therapy for Treatment of T1-T2 Oropharyngeal Squamous Cell CarcinomaDev R Amin, Ramez Philips, Dylan G Bertoni, et al.
JAMA Otolaryngology-- Head & Neck Surgery|July 31, 2025
Pathologic Treatment Effect and Survival in HPV-Negative HNSCC Following Neoadjuvant NivolumabAnnie E Moroco, Kathryn Nunes, Angela Alnemri, et al.
Head & Neck|June 21, 2020
COVID-19 pandemic and health care disparities in head and neck cancer: Scanning the horizonEvan Graboyes, John Cramer, Karthik Balakrishnan, et al.
The Laryngoscope|December 16, 2015
Multicompartment metabolism in papillary thyroid cancerJoseph M Curry, Patrick Tassone, Paolo Cotzia, et al.
Journal for Immunotherapy of Cancer|August 3, 2023
Nivolumab and ipilimumab in combination with radiotherapy in patients with high-risk locally advanced squamous cell carcinoma of the head and neckJennifer M Johnson, Ioannis A Vathiotis, Larry A Harshyne, et al.
Oral Oncology|January 20, 2026
Accuracy of frozen section for HPV-Associated squamous cell carcinoma of unknown primarySindhura Sridhar, Annie Moroco, Shravan Gowrishankar, et al.
Cancer Medicine|June 7, 2024
Predictive capacity of immune-related adverse events and cytokine profiling in neoadjuvant immune checkpoint inhibitor trials for head and neck squamous cell carcinomaAngela E Alnemri, Sruti Tekumalla, Annie E Moroco, et al.
Pageof 9

Showing results (61-70 of 90) with videos related to

Sort By:
Pageof 9
Biomed Research International|January 19, 2016
Prognostic Indications of Elevated MCT4 and CD147 across Cancer Types: A Meta-AnalysisCory D Bovenzi, James Hamilton, Patrick Tassone, et al.
JAMA Otolaryngology-- Head & Neck Surgery|July 3, 2024
Obesity and Survival After Immune Checkpoint Inhibition for Head and Neck Squamous Cell CarcinomaEric V Mastrolonardo, Pablo Llerena, Joseph Lu, et al.
Cancer|October 3, 2023
Effect of preoperative programmed death-1 or programmed death ligand-1 immune check point inhibition on complications after surgery for primary head and neck cancerRamez Philips, Angela Alnemri, Dev Amin, et al.
JAMA Otolaryngology-- Head & Neck Surgery|July 9, 2023
Differences in Functional and Survival Outcomes Between Patients Receiving Primary Surgery vs Chemoradiation Therapy for Treatment of T1-T2 Oropharyngeal Squamous Cell CarcinomaDev R Amin, Ramez Philips, Dylan G Bertoni, et al.
JAMA Otolaryngology-- Head & Neck Surgery|July 31, 2025
Pathologic Treatment Effect and Survival in HPV-Negative HNSCC Following Neoadjuvant NivolumabAnnie E Moroco, Kathryn Nunes, Angela Alnemri, et al.
Head & Neck|June 21, 2020
COVID-19 pandemic and health care disparities in head and neck cancer: Scanning the horizonEvan Graboyes, John Cramer, Karthik Balakrishnan, et al.
The Laryngoscope|December 16, 2015
Multicompartment metabolism in papillary thyroid cancerJoseph M Curry, Patrick Tassone, Paolo Cotzia, et al.
Journal for Immunotherapy of Cancer|August 3, 2023
Nivolumab and ipilimumab in combination with radiotherapy in patients with high-risk locally advanced squamous cell carcinoma of the head and neckJennifer M Johnson, Ioannis A Vathiotis, Larry A Harshyne, et al.
Oral Oncology|January 20, 2026
Accuracy of frozen section for HPV-Associated squamous cell carcinoma of unknown primarySindhura Sridhar, Annie Moroco, Shravan Gowrishankar, et al.
Cancer Medicine|June 7, 2024
Predictive capacity of immune-related adverse events and cytokine profiling in neoadjuvant immune checkpoint inhibitor trials for head and neck squamous cell carcinomaAngela E Alnemri, Sruti Tekumalla, Annie E Moroco, et al.
Pageof 9